| Net income (loss) | -9.34M |
| Depreciation | |
| Amortization | |
| Change in fair value of derivative instruments | -661K |
| Non-cash interest expense | |
| Non-cash compensation expense | 173K |
| Gain on disposal of fixed assets | |
| (Increase) decrease in accounts receivable | 209K |
| Increase in inventory | 30K |
| Increase in prepaid expenses and other current assets | 633K |
| Increase in deferred revenue | 46K |
| (Decrease) increase in accounts payable and accrued expenses | -1.24M |
| Increase (decrease) in other current liabilities | |
| Decrease in deferred lease liability | -5K |
| Decrease in restructuring accrual | |
| Total adjustments | 5.18M |
| Net cash used in operating activities | |
| Net cash provided by investing activities - proceeds from sale of fixed assets | |
| Net cash provided by financing activities - proceeds from exercise of warrants | |
| Net decrease in cash and cash equivalents | -4.16M |
| Cash and cash equivalents, beginning of period | 12.9M |
| Cash and cash equivalents, end of period | 8.74M |
| Common stock issued to settle accrued Directors compensation | |
| Exchange of debt as deferred revenue | |
| Reclassification of derivative liability to equity upon exercise of warrants | |